Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

2.

Researchers explore e-bikes for cancer recovery

3.

According to new studies, some cancer patients can safely forego radiation therapy.

4.

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

5.

A single bout of exercise gives results that could help cancer patients


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot